Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition

Revenue and margins fell sharply; losses widened despite a new asset acquisition.

What the company is saying

Radnostix, Inc. presents its Q2 and H1 2026 financials with a focus on declining revenue and profitability, while highlighting a recent acquisition and a new sales contract. The narrative acknowledges a 27% year-over-year drop in both quarterly and six-month revenues, with gross profit and margins also down significantly. Management emphasizes the acquisition of Lucerno Dynamics' assets, specifically the Lara System and Ellexa Explorer Software, as a strategic move. The announcement points to a contracted $1.2 million in second half Cobalt Products sales as a near-term positive. Operational recovery and product commercialization are framed as ongoing priorities, but the tone remains factual and avoids promotional language. The company does not attempt to minimize the negative financial trends or inflate the impact of the acquisition.

What the data suggests

The numbers show a deteriorating financial position: Q2 2026 revenue dropped to $2.67 million, down 27% from the prior year, and six-month revenue fell to $5.05 million, also a 27% decline. Gross profit margins compressed from 59% to 51% in Q2, and from 61% to 50% for the half, while gross profit dollars nearly halved. Net loss for the quarter widened to $0.88 million from $0.16 million, and the six-month net loss ballooned to $2.23 million from $0.27 million. Cash at quarter-end stood at $1.2 million, signaling limited liquidity. Segment data reveals Theranostics Products revenue fell 43% in Q2, while Calibration & Reference Products grew 4%. The $1.2 million in contracted Cobalt Products sales for the second half provides some revenue visibility, but does not offset the overall decline. EBITDA and adjusted EBITDA were both negative, at ($705,342) and ($585,697) respectively. Disclosures are detailed for headline metrics, but lack expense breakdowns and cash flow specifics.

Analysis

The announcement is factual and restrained, with no evidence of exaggerated or promotional language. The majority of claims are realised and supported by detailed numerical disclosures, including revenue, gross profit, net loss, and EBITDA. The only forward-looking claim is the contracted $1.2 million in second half Cobalt Products sales, which is described as 'contracted' and thus likely to be realised in the near term. The acquisition of Lucerno Dynamics' assets is a capital-intensive move, but the announcement does not overstate its immediate benefits or make speculative claims about future performance. Financial results show a clear deterioration in revenue, margins, and net income, and these negative trends are not downplayed or spun positively. There is no narrative inflation or attempt to mask the weak financial performance.

Risk flags

• ●Sustained revenue and margin declines indicate structural demand or operational issues, with Q2 and H1 revenue both down 27% and gross margins compressing by 8–11 percentage points. This trend raises questions about the company's ability to stabilize or grow its core business.
• ●Net losses have widened sharply, with the quarterly loss increasing more than fivefold year-over-year and six-month losses up eightfold. Persistent losses and negative EBITDA signal ongoing cash burn, which is concerning given the modest $1.2 million cash balance.
• ●The Lucerno Dynamics asset acquisition adds capital intensity and integration risk. There is no evidence yet that these assets will generate material revenue or margin improvement, and the company provides no detail on acquisition cost, synergies, or integration timeline.
• ●The $1.2 million in contracted Cobalt Products sales is a positive, but it is not enough to reverse overall financial deterioration. Execution risk remains if customers delay or cancel, or if operational issues persist in other segments.

Bottom line

Radnostix, Inc.'s Q2 2026 results reveal a company under financial pressure, with double-digit revenue declines, shrinking gross margins, and sharply higher losses. The acquisition of Lucerno Dynamics' assets is a strategic bet, but the lack of detail on integration or expected returns means its impact is uncertain. The only near-term positive is the contracted Cobalt Products sales, which will help stabilize revenue but not restore profitability. With just $1.2 million in cash and ongoing negative EBITDA, liquidity risk is rising unless operational recovery or new commercial wins materialize. For this update to become actionable, investors would need to see evidence of revenue stabilization, margin improvement, or successful commercialization of new products. The most important takeaway is that the company's financial trajectory is negative, and the new assets have yet to demonstrate value.

Announcement summary

(OTCQB:INIS) Radnostix, Inc. (formerly International Isotopes Inc.) announced its financial results for the second quarter and six months ended June 30, 2026, reporting total revenue for the three months ended June 30, 2026 was $2.67 million, a 27% decrease from $3.66 million in the prior-year period. Revenue for the six months ended June 30, 2026 was $5.05 million, also down 27% from $6.89 million in the first half of 2025. Gross profit for the quarter was $1.36 million (51% margin) compared with $2.14 million (59% margin) in Q2 2025. Net loss for the quarter was $0.88 million compared with $0.16 million in Q2 2025. Cash and cash equivalents were $1.20 million at June 30, 2026. The Company acquired the Lucerno Dynamics' assets, including the Lara System technology platform and Ellexa Explorer Software, on June 25, 2026. The Company contracted for additional $1.2 million in second half sales for Cobalt Products.

Disagree with this article?